Skip to content

Care Managers for Perinatal Depression (CMPD)

Care Managers for Perinatal Depression (CMPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01773629
Acronym
CMPD
Enrollment
194
Registered
2013-01-23
Start date
2010-09-30
Completion date
2013-12-31
Last updated
2014-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Pregnancy

Keywords

Depression, Pregnancy, Postpartum, Perinatal

Brief summary

The investigators will evaluate effects of introducing the care manager on: 1. Patient receipt of timely diagnosis and initiation of treatment for major depression (diagnosis within 2 weeks of screening and treatment within 1 month of diagnosis); and 2. Patient continuity of care for depression across the transition of care from pregnancy to postpartum (within 4 months postpartum).

Detailed description

The first two specific research aims of this proposed randomized study will evaluate the benefits of introducing site specific care managers into established multi-component enhancements of perinatal depression care. The four study sites are members of the IMPLICIT perinatal quality improvement network and provide prenatal care to a diverse population of low income minority women using a common set of care processes within diverse practice models including Obstetric, Family Medicine, and Nurse Practitioner/Midwifery settings. The established processes of care include evidence based screening, diagnosis, treatment protocols and quality improvement care teams. The investigators will evaluate effects of introducing the care manager on: 1. Patient receipt of timely diagnosis and initiation of treatment for major depression (diagnosis within 2 weeks of screening and treatment within 1 month of diagnosis); and 2. Patient continuity of care for depression across the transition of care from pregnancy to postpartum (within 4 months postpartum). For the third and fourth specific research aims we will conduct supplementary econometric and qualitative analyses to aid in understanding the provider and system context in which this intervention is implemented across the four study sites. Results of this evaluation will be used to understand for whom and in which systems of care this model is most successful as well as the costs of delivering this intervention. Specifically the investigators will: 1. Employ econometric techniques to quantify the costs of implementing and maintaining the IMPLICIT collaborative care maternal depression intervention; and 2. Develop institutional ethnographies of the four study sites and identify factors associated with relative success in implementing perinatal depression care managers and improving timely diagnosis, initiation, and continuity of depression care. Achieving these aims will provide the foundation for dissemination of this innovative approach to perinatal depression care delivery throughout the entire growing IMPLICIT network which now extends across the northeast and mid-Atlantic regions of the US; sites which provide perinatal care for low income minority women in urban, rural, and suburban communities. These sites include prenatal practices in the Robert Wood Johnson Foundation Aligning Forces for Quality initiative, the Healthy York County Coalition which is partnering with us to disseminate this work in their region.

Interventions

OTHERIntervention

Participants in the intervention arm will receive standard care plus the addition of a care manager. Care managers will function to provide culturally competent and linguistically appropriate support for the care of women identified as being at high risk for depression in pregnancy. Working with both the care providers and these study participants care managers will serve as connectors, coaches, collaborators, and negotiators working to overcome barriers to depression care delivery.

OTHERControl

Standard of care: within the current care processes, a woman initiating prenatal care completes a depression risk assessment using a two-step approach. Women with high risk of depression are then scheduled for a separate visit with a member of the care team (a physician, psychologist, or other mental health provider) referred to as a perinatal depression champion for a timely formal diagnostic interview.

Sponsors

University of Pennsylvania
CollaboratorOTHER
Robert Wood Johnson Foundation
CollaboratorOTHER
Lancaster General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * Current pregnancy or experienced pregnancy in the past 6 weeks * Score \>= 12 on PHQ9

Exclusion criteria

* \< age 13 * Mental illness * Primary language other than English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of major depression within 2 weeks of screening2 weeks after screeningPatient receipt of timely diagnosis for major depression during perinatal period.
Treatment of major depression within 1 month of diagnosis1 monthPatient receipt of timely initiation of treatment for major depression during the perinatal period.
Transition of care from pregnancy to postpartum4 monthsPatient continuity of care for depression across the transition of care from pregnancy to postpartum within 4 months postpartum.

Secondary

MeasureTime frameDescription
Quantify the costs of implementing a care manager3 yearsEmploy econometric techniques to quantify the costs of implementing and maintaining the care manager for managing perinatal depression.
Qualitative assessment of success in implementation of perinatal depression care management process.3 yearsDevelop institutional ethnographies of the study sites and identify factors associated with relative success in implementing perinatal depression care managers and improving timely diagnosis, initiation, and continuity of depression care. Qualitative measures include efficacy of core implementation group, commitment of implementation group, commitment of user group and readiness to change.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026